Position in VNDA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$10,571,375
-$1,670,331 QoQ
Shares Held
1,727,349
-2.5% QoQ
Ownership
2.86%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 172 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 4%
None 4%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. VNDA ranks #80 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in VNDA
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,571,375 | 1,727,349 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $12,241,706 | 1,771,593 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $18,684,533 | 2,118,428 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $12,794,203 | 2,563,969 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $12,204,771 | 2,585,757 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $11,657,105 | 2,539,675 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $11,920,003 | 2,488,519 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $10,604,514 | 2,261,091 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $11,378,007 | 2,013,807 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $7,075,917 | 1,721,635 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $8,304,894 | 1,967,985 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $9,350,889 | 2,164,558 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $12,846,432 | 1,949,383 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $18,901,253 | 2,783,690 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $21,089,815 | 2,853,832 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $27,021,561 | 2,734,976 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $29,212,271 | 2,680,025 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $25,596,328 | 2,263,159 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $31,906,838 | 2,033,578 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $33,078,177 | 1,929,882 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 ALXN | — | 1,314,023 | Shares | Defined | 2021-08-12 | |
| 2021-06-30 | $42,297,844 | 1,966,427 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 ALXN | — | 1,315,940 | Shares | Defined | 2021-05-14 | |
| 2021-03-31 | $25,959,982 | 1,728,361 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 ALXN | — | 1,320,277 | Shares | Defined | 2021-03-08 | |
| 2020-12-31 | $20,396,407 | 1,552,238 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 ALXN | — | 1,379,373 | Shares | Defined | 2020-11-12 | |
| 2020-09-30 | $14,177,643 | 1,467,665 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 ALXN | — | 1,354,917 | Shares | Defined | 2020-08-13 | |
| 2020-06-30 | $16,393,611 | 1,433,008 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 ALXN | — | 1,222,599 | Shares | Defined | 2020-05-14 | |
| 2020-03-31 | $13,834,174 | 1,335,345 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||